Barclays
KBIO

Barclays’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Barclays’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-9
Closed – – 6915
2015
Q4 		$0 Buy
+9
New +$100 ﹤0.01% 7336
2014
Q4 		– Sell
-2,193
Closed -$18K – 8053
2014
Q3 		$18K Sell
2,193
-99
-4% -$1.36K ﹤0.01% 6571
2014
Q2 		$37K Sell
2,292
-269
-11% -$4.6K ﹤0.01% 6156
2014
Q1 		$41K Buy
2,561
+264
+11% +$7.65K ﹤0.01% 6163
2013
Q4 		$73K Buy
2,297
+1,599
+229% +$53.6K ﹤0.01% 5918
2013
Q3 		$22K Sell
698
-118
-14% -$5.38K ﹤0.01% 6500
2013
Q2 		$37K Buy
+816
New +$37K ﹤0.01% 6521

Other funds holding KBIO

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Barclays's KBIO Position: Q1 2016 in Review

Barclays sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2016, closing a stake of 9 shares.

Barclays first reported a position in KBIO in Q2 2013 and held it in 7 quarters. The position peaked at $73K in Q4 2013. 1 fund tracked by Wall St. Rank holds KBIO as of Q1 2016.

  • Barclays reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2016 after selling out during the quarter.
  • Barclays sold 9 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2016.
  • Barclays first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q2 2013 and held it in 7 quarters.
  • Barclays's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $73K in Q4 2013.
  • 1 fund tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2016.

Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.